Torre DM, Wang NY, Meoni LA, et al. Suicide compared to other causes of mortality in physicians. Suicide Life Threat Behav.
O'Connor PG, Spickard A Jr. Physician impairment by substance abuse. Med Clin North Am.
Hughes PH, Brandenburg N, Baldwin DC Jr, et al. Prevalence of substance use among US Physicians. JAMA.
Talbott GD, Wright C. Chemical dependency in health care professionals. Occup Med.
Morse RM, Flavin DK. The definition of alcoholism. The Joint Committee of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism. JAMA.
SAMHSA. Results from the 2005 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies NSDUH Series H-30 2006; US Dept of Health and Human Services; 2006. DHHS publication SMA 06-4194.
Nelson DE, Giovino GA, Emont SL, et al. Trends in cigarette smoking among US physicians and nurses. JAMA.
Kenna GA, Wood MD. Alcohol use by healthcare professionals. Drug Alcohol Depend.
Hughes PH, Storr C, Baldwin DC Jr, et al. Patterns of substance use in the medical profession. Md Med J.
Luck S, Hedrick J. The alarming trend of substance abuse in anesthesia providers. J Perianesth Nurs.
Merlo LJ, Gold MS. Prescription opioid abuse and dependence among physicians: hypotheses and treatment. Harv Rev Psychiatry. 2008;16:181-194.
Kleber HD. The impaired physician: changes from the traditional view. J Subst Abuse Treat.
Koob GF, Le Moal M. Plasticity of reward neurocircuitry and the “dark side” of drug addiction. Nat Neurosci.
Le Moal M, Koob GF. Drug addiction: pathways to the disease and pathophysiological perspectives. Euro Neuropsychopharm.
Gold MS, Byars JA, Frost-Pineda K. Occupational exposure and addictions for physicians: case studies and theoretical implications. Psych Clin North Am.
Gold MS, et al. Fentanyl is present in the air and operating room surfaces. J Addict Dis.
McAuliffe PF, Gold MS, Bajpai L, et al. Second-hand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. Med Hypotheses.
Emshoff JG, Price AW. Prevention and intervention strategies with children of alcoholics. Pediatrics.
Roy A. Suicide in doctors. Psychiatr Clin North Am.
Graham C. Poland wrestles with the problem of drunken doctors. Lancet.
Taub S, Morin K, Goldrich MS, et al. Physician health and wellness. Occup Med (Lond).
Pomm RM, Harmon L. Evaluation and posttreatment monitoring of the impaired physician. Psychiatr Ann.
Council on Ethical and Judicial Affairs of the American Medical Association. Reporting Impaired, Incompetent, or Unethical Colleagues, in Reports of the Council on Ethical and Judicial Affairs.
Chicago: American Medical Association; January 1992.
Angres D, Busch K. The Chemically-dependent physician: clinical and legal considerations. In: Miller RD, ed. Legal Implications of Hospital Policies and Procedures.
San Francisco: Jossey-Bass; 1989:21-32.
Breiner SJ. The impaired physician. J Med Educ.
Vaillant GE, Clark W, Cyrus C, et al. Prospective study of alcohol treatment. Eight year follow-up. Am J Med.
Farber NJ, Gilibert SG, Aboff BM, et al. Physicians’ willingness to report impaired colleagues. Soc Sci Med.
Skipper GE. Treating the chemically dependent health professional. J Addict Dis.
Roback HB, Moore RF, Waterhouse GJ, Martin PR. Confidentiality dilemmas in group psychotherapy with substance-dependent physicians. Am J Psychiatry.
McGovern MP, Angres DH, Leon S. Differential therapeutics and the impaired physician: patient-treatment matching by specificity and intensity. J Addict Dis.
Angres DH, McGovern MP, Shaw MF, Rawal P. Psychiatric comorbidity and physicians with substance use disorders: a comparison between the 1980s and 1990s. J Addict Dis.
Wijesinghe CP, Dunne F. Substance use and other psychiatric disorders in impaired practitioners. Psychiatr Q.
American Society of Addiction Medicine. Patient Placement Criteria.
Chevy Chase, MD: American Society of Addiction Medicine; 2000.
Enders LE, Mercier JM. Treating chemical dependency: the need for including the family. Int J Addict.
Eells MA. Interventions with alcoholics and their families. Nurs Clin North Am.
Gallegos KV, Lubin BH, Bowers C, et al. Relapse and recovery: five to ten year follow-up study of chemically dependent physicians—the Georgia experience. Md Med J.
Galanter M, Talbott D, Gallegos K, Rubenstone E. Combined Alcoholics Anonymous and professional care for addicted physicians. Am J Psychiatry.
Moos RH, Moos BS. Paths of entry into Alcoholics Anonymous: consequences for participation and remission. Alcohol Clin Exp Res.
Walsh DC, Hingson RW, Merrigan DM, et al. A randomized trial of treatment options for alcohol-abusing workers. N Engl J Med.
Crowley TJ. Doctors’ drug abuse reduced during contingency-contracting treatment. Alcohol Drug Res.
Washton AM, Gold MS, Pottash AC. Naltrexone in addicted physicians and business executives. NIDA Res Monogr.
Vinson S, Graham NA, Gold MS. Socioeconomic inequities often translate into health inequalities. J Natl Med Assoc.
Gold MS, Pomm R, Frost-Pineda K. Urine testing confirmed, 5-year outcomes of impaired physicians. World Psychiatric Association; November 2004; Florence, Italy.
Gold MS, Frost-Pineda K. Problem doctors: is there a system level solution? Ann Intern Med.
Jacobs WS, Repetto M, Vinson S, et al. Random urine testing as an intervention for drug addiction. Psychiatr Ann.
Shore JH. The Oregon experience with impaired physicians on probation. An eight year follow-up. JAMA.
Domino KB, Hornbein TF, Polissar NL, et al. Risk factors for relapse in health care professionals with substance use disorders. JAMA.
Gossop M, Stephens S, Stewart D, et al. Health care professionals referred for treatment of alcohol and drug problems. Alcohol Alcohol.
Gold MS, Frost-Pineda K, Melker RJ. Physician suicide and drug abuse. Am J Psychiatry.
Talbott GD, Martin CA. Relapse and recovery: special issues for chemically dependent physicians. J Med Assoc Ga.
Gallegos KV, Keppler JP, Wilson PO. Returning to work after rehabilitation: aftercare, follow-up, and workplace reliability. Occup Med.
Morse RM, Martin MA, Swenson WM, Niven RG. Prognosis of physicians treated for alcoholism and drug dependence. JAMA.
Femino J, Nirenberg TD. Treatment outcome studies on physician impairment: a review of the literature. R I Med.
Herrington RE, Benzer DG, Jacobson GR, Hawkins MK. Treating substance-use disorders among physicians. JAMA.
Alpern F, Correnti CE, Dolan TE, et al. A survey of recovering Maryland physicians. Md Med J.
Boisaubin EV, Levine RE. Identifying and assisting the impaired physician. Am J Med Sci.
Gold MS, Frost-Pineda K, Goldberger BA, DuPont RL. Physicians and drug screening. J Adolesc Health.
DuPont RL, McLellan AT, White WL, et al. Setting the standard for recovery: Physicians’ Health Programs. J Subst Abuse Treat. 2009;36:159-171.
Gallegos KV, Lubin BH, Bowers C, et al. Relapse and recovery: five to ten year follow-up study of chemically dependent physicians—the Georgia experience. Md Med J. 1992;41:315-319.
White WL, DuPont RL, Skipper GE. Physicians health programs: what counselors can learn from these remarkable programs. Counselor: Mag Addict Prof. 2007; 8:42-47.